Mecanismos de acción y tratamiento del accidente cerebrovascular isquémico por COVID-19
Mechanisms of action and treatment of ischemic stroke by COVID-19Barra lateral del artículo
Contenido principal del artículo
Diversos mecanismos inflamatorios y protrombóticos pueden contribuir al aumento del riesgo de eventos cardiovasculares y accidentes cerebrovasculares en pacientes con COVID-19, afectando el enfoque del tratamiento y manejo de la enfermedad. La evidencia relacionada con los mecanismos fisiopatológicos del COVID-19 y su asociación con los accidentes cerebrovasculares son relevantes para guiar el tratamiento y el manejo de los pacientes, considerados como desafíos terapéuticos que surgen durante períodos de contagio masivo. Objetivo. Describir el mecanismo de acción y tratamiento del evento cerebro vascular isquémico por COVID-19. Metodología. Se realizó una revisión exhaustiva de la literatura mediante una revisión sistemática, en conformidad con las directrices establecidas por la declaración PRISMA. Se recopiló información de múltiples bases de datos científicas, utilizando términos y palabras clave ("Mecanismos de acción" OR "Mecanismos fisiopatológicos") AND ("Accidente cerebrovascular isquémico" OR "ACV isquémico") relacionados con los mecanismos de acción y tratamiento del accidente cerebrovascular isquémico asociado al COVID-19. Resultados. En total se obtuvo 41 entre PubMed y Science direct, previo a criterios 12 fueron seleccionados. Conclusión. Se determinaron los mecanismos de acción desencadenados por el COVID-19 para la formación de trombos y su relación con los accidentes cerebrovasculares. Además, se comprendió cómo el tratamiento de los accidentes cerebrovasculares afectaba a los pacientes que también padecían COVID-19. Se encontró que la tormenta de citocinas era un mecanismo influyente en la fisiopatología del COVID-19. En cuanto al tratamiento, la identificación de la enfermedad infecciosa causada por el virus SARS-CoV-2 resultó crucial en la gestión de los pacientes con accidente cerebrovascular
Various inflammatory and prothrombotic mechanisms may contribute to the increased risk of cardiovascular events and stroke in patients with COVID-19, affecting the approach to treatment and management of the disease. Evidence regarding the pathophysiological mechanisms of COVID-19 and its association with stroke are relevant to guide the treatment and management of patients, considered as therapeutic challenges arising during periods of massive contagion. Objective. To describe the mechanism of action and treatment of ischemic cerebrovascular event by COVID-19. Methodology. A comprehensive review of the literature was performed by means of a systematic review, in accordance with the guidelines established by the PRISMA statement. Information was collected from multiple scientific databases, using terms and keywords ("Mechanisms of action" OR "Pathophysiological mechanisms") AND ("Ischemic stroke" OR "Ischemic stroke") related to the mechanisms of action and treatment of COVID-19-associated ischemic stroke. Results. A total of 41 were obtained between PubMed and Science direct, prior to criteria 12 were selected. Conclusion. The mechanisms of action triggered by COVID-19 for thrombus formation and its relation to stroke were determined. In addition, we gained insight into how stroke treatment affected patients who also had COVID-19. Cytokine storm was found to be an influential mechanism in the pathophysiology of COVID-19. In terms of treatment, identification of infectious disease caused by SARS-CoV-2 virus proved crucial in the management of stroke patients
Descargas
Detalles del artículo
Casoli T. SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability. Int J Mol Sci. 2022; 23(7):3782. Doi: 10.3390/ijms23073782.
Shulman JG, Ford T, Cervantes-Arslanian AM. Neurologic Emergencies during the Coronavirus Disease 2019 Pandemic. Neurol Clin. 2021;39(2):671-87. Doi: https://10.1016/j.ncl.2021.02.007.
Vogrig A, Gigli GL, Bnà C, Morassi M. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics. Neurosci Lett. 2021; 743:135564. Doi: https://10.1016/j.neulet.2020.135564.
Chauca R. La covid-19 en Ecuador: fragilidad política y precariedad de la salud pública. Hist cienc saude-Manguinhos. junio de 2021;28(2):587-91.
Kolmos M, Christoffersen L, Kruuse C. Recurrent Ischemic Stroke - A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2021;30(8):105935. Doi: https://10.1016/j.jstrokecerebrovasdis.2021.105935.
Hassett CE, Frontera JA. Neurologic aspects of coronavirus disease of 2019 infection. Curr Opin Infect Dis. 2021;34(3):217-27. Doi: https://10.1097/QCO.0000000000000731.
Ranzani OT, Hitchings MDT, Dorion M, D'Agostini TL, de Paula RC, de Paula OFP, et al. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ. 2021;374: n2015. Doi: https://10.1136/bmj. n2015.
Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, Tu TM, Sharma VK, Yeo LLL, Chan BPL, Tan BYQ. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020;50(3):587-95. Doi: https://10.1007/s11239-020-02228-y.
Quintanilla-Sánchez C, Salcido-Montenegro A, González-González JG, RodríguezGutiérrez R. Acute cerebrovascular events in severe and nonsevere COVID-19 patients: a systematic review and meta-analysis. Rev Neurosci. 2022;33(6):631-9. Doi: https://10.1515/revneuro-2021-0130.
Sweid A, Hammoud B, Bekelis K, Missios S, Tjoumakaris SI, Gooch MR, Herial NA, Zarzour H, Romo V, DePrince M, Rosenwasser RH, Jabbour P. Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke. 2020;15(7):733-742. Doi: https://10.1177/1747493020937189.
Pizzi MA. Acute Neurologic Manifestations of Respiratory Viruses. Continuum (Minneap Minn). 2021;27(5):1365-81. Doi: https://10.1212/CON.0000000000001007.
Zhai P, Ding Y, Li Y. The impact of COVID-19 on ischemic stroke. Diagn Pathol. 2020;15(1):78. Doi: 10.1186/s13000-020-00994-0.
Siegler JE, Zha AM, Czap AL, Ortega-Gutierrez S, Farooqui M, Liebeskind DS, et al. Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke: The Society of Vascular and Interventional Neurology Multicenter Collaboration. Stroke.2021;52(1):40-7 Doi: https://10.1161/STROKEAHA.120.032789.
Sarubbo F, El Haji K, Vidal-Balle A, Bargay Lleonart J. Neurological consequences of COVID-19 and brain related pathogenic mechanisms: A new challenge for neuroscience. Brain, Behavior, & Immunity - Health. 2022; 19:100399. Doi: https://10.1016/j.bbih.2021.100399.
Romero JP, Bravo-Martín A, Oliva-Navarrete P, Sánchez-Cuesta F, Ríos-Lago M, Benito-León J. Impact of COVID-19 on a brain damage unit. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(4):102163. Doi: https://10.1016/j.dsx.2021.05.036.
Palmisano A, Gambardella M, D’Angelo T, Vignale D, Ascione R, Gatti M, et al. Advanced cardiac imaging in the spectrum of COVID-19 related cardiovascular involvement. Clinical Imaging. 2022; 90:78-89. Doi: https://10.1016/j.clinimag.2022.07.009.
Hamouche W, Bisserier M, Brojakowska A, Eskandari A, Fish K, Goukassian DA, et al. Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19. Journal of Molecular and Cellular Cardiology. 2021; 153:72-85. Doi: https://10.1016/j.yjmcc.2020.12.009
De Sousa Moreira JL, Barbosa SMB, Vieira JG, Chaves NCB, Felix EBG, Feitosa PWG, et al. The psychiatric and neuropsychiatric repercussions associated with severe infections of COVID-19 and other coronaviruses. Progress in NeuroPsychopharmacology and Biological Psychiatry. 2021; 106:110159. Doi: https://10.1016/j.pnpbp.2020.110159.
Ribes A, Vardon-Bounes F, Mémier V, Poette M, Au-Duong J, Garcia C, et al. Thromboembolic events and Covid-19. Advances in Biological Regulation. 2020; 77:100735. Doi: https://10.1016/j.jbior.2020.100735.
De Carranza M, Salazar DE, Troya J, Alcázar R, Peña C, Aragón E, et al. Aortic thrombus in patients with severe COVID-19: review of three cases. J Thromb Thrombolysis. 2021;51(1):237-42. Doi: https://10.1007/s11239-020-02219-z
Chibane S, Gibeau G, Poulin F, Tessier P, Goulet M, Carrier M, et al. Hyperacute multiorgan thromboembolic storm in COVID-19: a case report. J Thromb Thrombolysis. 2021;51(1):25-8. Doi: https://10.1007/s11239-020-02173-w.
Martí-Fàbregas J, Guisado-Alonso D, Delgado-Mederos R, Martínez-Domeño A, PratsSánchez L, Guasch-Jiménez M, et al. Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke. Stroke. 2021;52(12):3908-17. Doi: https://10.1161/STROKEAHA.121.034883
Zhang S, Zhang J, Wang C, Chen X, Zhao X, Jing H, et al. COVID?19 and ischemic stroke: Mechanisms of hypercoagulability (Review). Int J Mol Med. 2021;47(3):21. Doi: https://10.3892/ijmm.2021.4854
Gao X. The choice of intravenous thrombolysis for Acute Ischemic Stroke under COVID-19 infection. Clinical Neurology and Neurosurgery. 2020; 196:105968. Doi: https://10.1016/j.clineuro.2020.105968
Del Prete A, Conway F, Della Rocca DG, Biondi-Zoccai G, De Felice F, Musto C, et al. COVID-19, Acute Myocardial Injury, and Infarction. Cardiac Electrophysiology Clinics. 2022;14(1):29-39. Doi: https://10.1016/j.ccep.2021.10.004.
González-García Sergio, Garófalo-Gomez Nicolás, González-Quevedo Alina, Mezquia de Pedro Natascha. Infección por COVID-19 y accidente cerebrovascular. Rev Cubana Invest Bioméd [Internet]. 2021 Mar [citado 2022 Dic 14]; 40(1): e884. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002021000100014&lng=es. Epub 01-Abr-2021.
Scharpf W, Katsafanas C, Ng K. COVID-19-Associated Ischemic Stroke in a Patient on Therapeutic Anticoagulation. Neurologist. 2021;26(3):108-11. Doi: https://10.1097/NRL.0000000000000319.
Cho, Sung-Min DO, Premraj, Lavienraj, Fanning, Jonathon, Huth, et al. Ischemic and Hemorrhagic Stroke Among Critically Ill Patients with Coronavirus Disease 2019: An International Multicenter Coronavirus Disease 2019 Critical Care Consortium Study*. Critical Care Medicine:2021;49(12): e1223-e1233. Doi: https://10.1097/CCM.0000000000005209
Marín-Medina DS, Muñoz-Rosero AM, Bernal-Bastidas BL, Gaspar-Toro JM. Infección por SARS-CoV-2 y ataque cerebrovascular isquémico [SARS-CoV-2 infection and ischemic stroke]. Semergen. 2021;47(7):482-87.
Garcés MP, García ME. Enfermedad cerebrovascular durante la pandemia de COVID19. Revista cubana de medicina intensiva y emergencias. [Internet]. 2020 Mar [citado 2022 Dic 14];19(4): e778. Disponible en: https://www.medigraphic.com/pdfs/revcubmedinteme/cie-2020/cie204g.pdf